TickerFactsScreenerDevelopers

Theriva Biologics, Inc. (TOVX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$1.15M2011: -$2.88M2012: -$8.92M2013: -$7.72M2014: -$16.08M2015: -$38.89M2016: -$27.90M2017: -$20.20M2018: -$17.28M2019: -$13.87M2020: -$12.17M2021: -$12.89M2022: -$19.08M2023: -$19.00M2024: -$16.94M2025: -$16.67M-$16.67M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$16.67M+1.6%
2024-$16.94M+10.8%
2023-$19.00M+0.5%
2022-$19.08M-48.0%
2021-$12.89M-5.9%
2020-$12.17M+12.3%
2019-$13.87M+19.7%
2018-$17.28M+14.5%
2017-$20.20M+27.6%
2016-$27.90M+28.3%
2015-$38.89M-141.9%
2014-$16.08M-108.3%
2013-$7.72M+13.4%
2012-$8.92M-210.1%
2011-$2.88M-151.1%
2010-$1.15M—